Welcome to our dedicated page for Talphera news (Ticker: TLPH), a resource for investors and traders seeking the latest updates and insights on Talphera stock.
Talphera, Inc. reports news centered on its specialty pharmaceutical development business, with recurring updates on Niyad, nafamostat research, continuous renal replacement therapy and medically supervised care settings. Company announcements commonly cover financial results, corporate updates, clinical-study developments, research presentations and regulatory designations tied to the Niyad program.
Other recurring Talphera news includes financings involving common stock and pre-funded warrants, board and governance changes, investor events and business updates related to its development-stage pharmaceutical portfolio.
Talphera (Nasdaq: TLPH), a specialty pharmaceutical company, has announced its participation in the A.G.P. Virtual Healthcare Conference on May 21, 2024, at 10:40 a.m. ET. The management will engage in a fireside chat format to discuss the company's innovative therapies developed for medically supervised settings. This session aims to provide insights into Talphera's business strategies and future plans. Attendees can join the webcast through a provided link.
Talphera (Nasdaq: TLPH) announced its Q1 2024 financial results and provided a corporate update. The company reported cash and investments of $18.6 million as of March 31, 2024. Combined R&D and SG&A expenses were $4.2 million, down from $5.3 million in Q1 2023, due to reduced headcount from divesting DSUVIA. Net loss from continuing operations was $4.0 million, compared to net income of $0.1 million in Q1 2023, due to changes in the fair value of the company's warrant liability. The NEPHRO CRRT study is set to enroll its first patients in Q2 2024. Dr. Shakil Aslam joins as Chief Development Officer on May 20, 2024.
Talphera, Inc. (NASDAQ: TLPH) will release its first quarter 2024 financial results on May 14, 2024, followed by a live webcast and conference call to discuss the results and provide a business update. The webcast can be accessed on the company's website, and the conference call details are provided for investors.
Summary not available.
Summary not available.
Summary not available.
Summary not available.